Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor

Details for Australian Patent Application No. 2004214988 (hide)

Owner GenVec, Inc.

Inventors Brough, Douglas E.

Agent Pizzeys

Pub. Number AU-A-2004214988

PCT Pub. Number WO2004/076626

Priority 10/373,249 24.02.03 US

Filing date 19 February 2004

Wipo publication date 10 September 2004

International Classifications

C12N 015/86 Mutation or genetic engineering - Viral vectors

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/076626 Priority application(s): WO2004/076626

10 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004215005-Hydrocarbon gas processing

2004214977-Methods of screening for TRPM5 modulators